Cyclic AMP signaling pathway modulates susceptibility of candida species and Saccharomyces cerevisiae to antifungal azoles and other sterol biosynthesis inhibitors.
about
Regulatory circuitry governing fungal development, drug resistance, and disease.A mitochondrial CO2-adenylyl cyclase-cAMP signalosome controls yeast normoxic cytochrome c oxidase activity.Disruption of the transcriptional regulator Cas5 results in enhanced killing of Candida albicans by FluconazoleNew Fks hot spot for acquired echinocandin resistance in Saccharomyces cerevisiae and its contribution to intrinsic resistance of Scedosporium speciesEnvironmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans.The Ssk1p response regulator and Chk1p histidine kinase mutants of Candida albicans are hypersensitive to fluconazole and voriconazole.An update on antifungal targets and mechanisms of resistance in Candida albicans.Genome-wide transcriptional profiling of the cyclic AMP-dependent signaling pathway during morphogenic transitions of Candida albicansMiconazole: a historical perspective.Molecular Characterization of Gβ-Like Protein CpcB Involved in Antifungal Drug Susceptibility and Virulence in A. fumigatusIdentification of the putative protein phosphatase gene PTC1 as a virulence-related gene using a silkworm model of Candida albicans infectionStress, drugs, and evolution: the role of cellular signaling in fungal drug resistanceEfflux-mediated antifungal drug resistance.Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesisGlobal Role of Cyclic AMP Signaling in pH-Dependent Responses in Candida albicans.Antifungal research strategies aiming for new targets.The Ras/cAMP/PKA signaling pathway and virulence in Candida albicans.Baker's yeast as a tool for the development of antifungal drugs which target cell integrity - an update.Novel Regulatory Mechanisms of Pathogenicity and Virulence to Combat MDR in Candida albicans.The Rho1 GTPase-activating protein CgBem2 is required for survival of azole stress in Candida glabrataThe development of fluconazole resistance in Candida albicans - an example of microevolution of a fungal pathogen.The fungal resistome: a risk and an opportunity for the development of novel antifungal therapies.Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae.Regulated proteolysis of Candida albicans Ras1 is involved in morphogenesis and quorum sensing regulation.Identification and functional characterization of Rca1, a transcription factor involved in both antifungal susceptibility and host response in Candida albicans.Chemogenomic profiling of the fungal pathogen Candida albicans.Candida albicans Heat Shock Proteins and Hsps-Associated Signaling Pathways as Potential Antifungal Targets.Subcellular compartmentation, interdependency and dynamics of the cyclic AMP-dependent PKA subunits during pathogenic differentiation in rice blast.Cyclic AMP Pathway Activation and Extracellular Zinc Induce Rapid Intracellular Zinc Mobilization in Candida albicans.
P2860
Q34190284-2C6EF5E6-A063-4C9D-BCCF-5A4D2202D03EQ34365528-94DFFF99-278D-494F-BA73-5A28618C5926Q34596791-717F1359-98DD-48C7-9FB5-DE83E4F73722Q35139501-C5CEEAF0-2D22-4F55-BA9E-170CB4020BBDQ35856686-99A8174B-1A6F-422E-951D-531F2203874AQ36095050-3893A1FB-1342-4AF7-A94B-01079A1E66FDQ36235037-CC3EAD93-189B-4354-ABAA-1C8567F1EDB7Q36313748-0AA55002-71E9-4D9B-9F6A-BE533197552FQ36441479-04FA283D-FB4F-47CE-8303-DCBDE60786D3Q36559089-D3C5D48C-EF8E-44EC-9F51-A6D9B79CD6F5Q36939030-EE7C3B15-9F3B-4A8B-BA6A-1399D18F1693Q37122826-9ECDF29F-4689-4634-86F9-96794C5D88FFQ37156645-2AC230F8-26C9-4EF2-91F0-E51D3B1CF26EQ37195641-FE3A9F50-BCCB-4549-8C5A-31006A41A3CBQ37472871-89CC6336-B2E7-4663-BDFE-6ACB2F8A119CQ37588637-89408C1E-FC69-4C07-B1E3-3ADCD89A3B39Q37648692-9459FDAB-578B-4A9C-BE11-CDAA7859C82BQ38088803-34773825-1347-4EDA-B87F-AF15A7451E06Q38155848-0872C538-5888-4D5C-A4FE-DFED9B8BD847Q38674199-6D916D99-9C13-4220-A19D-72271C55E902Q38752384-B681637B-32FF-4860-B903-68325AF1AF71Q38835045-F0E01489-8E1D-46EF-8663-71465BABA9BBQ42035911-436B6AAF-2122-47FF-A815-B1E39F87A915Q42138343-0A6B097E-96B9-43CF-B3D5-AD88B672EF70Q42271039-B3895500-BEF9-41E9-8174-88AD204ED420Q46248402-7D02D9A0-F410-451E-8743-25017C05A82AQ47220163-66D8F218-45BF-4F67-B6E3-CF96564FD65FQ48096101-0920A5B1-2932-40E4-84D9-199300D19F73Q55033905-832E3467-3203-46D7-B4D6-169E7B6DBA98
P2860
Cyclic AMP signaling pathway modulates susceptibility of candida species and Saccharomyces cerevisiae to antifungal azoles and other sterol biosynthesis inhibitors.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Cyclic AMP signaling pathway m ...... terol biosynthesis inhibitors.
@ast
Cyclic AMP signaling pathway m ...... terol biosynthesis inhibitors.
@en
type
label
Cyclic AMP signaling pathway m ...... terol biosynthesis inhibitors.
@ast
Cyclic AMP signaling pathway m ...... terol biosynthesis inhibitors.
@en
prefLabel
Cyclic AMP signaling pathway m ...... terol biosynthesis inhibitors.
@ast
Cyclic AMP signaling pathway m ...... terol biosynthesis inhibitors.
@en
P2093
P2860
P1476
Cyclic AMP signaling pathway m ...... terol biosynthesis inhibitors.
@en
P2093
Indira Akula
Pooja Jain
Thomas Edlind
P2860
P304
P356
10.1128/AAC.47.10.3195-3201.2003
P407
P577
2003-10-01T00:00:00Z